Showing 1 to 12 of 231 results
NICE Approves Robotic Surgery Systems for NHS
The National Institute for Health and Care Excellence (NICE) approved eleven robotic surgery systems for use in the NHS for the next three years, costing between £500,000-£1.5 million each, to improve surgical precision and patient outcomes, following a surge in use for bowel and orthopaedic procedu...
NICE Approves Robotic Surgery Systems for NHS
The National Institute for Health and Care Excellence (NICE) approved eleven robotic surgery systems for use in the NHS for the next three years, costing between £500,000-£1.5 million each, to improve surgical precision and patient outcomes, following a surge in use for bowel and orthopaedic procedu...
Progress
48% Bias Score
Inaccurate Blood Tests from Synnovis Cause NHS Chaos
A London-based blood testing company, Synnovis, which provides services to nearly 200 GP surgeries and six hospitals, has been issuing inaccurate blood test results since 2021, causing patient distress, unnecessary hospital referrals, and wasted appointments; this follows a major cyberattack in 2022...
Inaccurate Blood Tests from Synnovis Cause NHS Chaos
A London-based blood testing company, Synnovis, which provides services to nearly 200 GP surgeries and six hospitals, has been issuing inaccurate blood test results since 2021, causing patient distress, unnecessary hospital referrals, and wasted appointments; this follows a major cyberattack in 2022...
Progress
48% Bias Score
NHS Fast-Tracks Melanoma Vaccine Access
The NHS will provide fast-tracked access to a new melanoma vaccine, iSCIB1+, for advanced melanoma patients in England, aiming to prevent recurrence and potentially saving lives; up to 10,000 patients will receive personalized cancer treatments by 2030.
NHS Fast-Tracks Melanoma Vaccine Access
The NHS will provide fast-tracked access to a new melanoma vaccine, iSCIB1+, for advanced melanoma patients in England, aiming to prevent recurrence and potentially saving lives; up to 10,000 patients will receive personalized cancer treatments by 2030.
Progress
48% Bias Score
NHS Approves Capivasertib for Advanced Breast Cancer
The NHS approved capivasertib, a twice-daily pill, for HR-positive HER2-negative breast cancer with specific gene mutations, benefiting up to 3,000 women yearly by extending progression-free survival by 4.2 months; this follows extensive research and clinical trials.
NHS Approves Capivasertib for Advanced Breast Cancer
The NHS approved capivasertib, a twice-daily pill, for HR-positive HER2-negative breast cancer with specific gene mutations, benefiting up to 3,000 women yearly by extending progression-free survival by 4.2 months; this follows extensive research and clinical trials.
Progress
36% Bias Score
UK Health Secretary Backs National Prostate Cancer Screening
UK Health Secretary Wes Streeting declared support for a national prostate cancer screening program, prioritizing high-risk men (Black men or those with family history), following a poll showing 94% of GPs favor the initiative and research suggesting 775 extra early diagnoses annually.
UK Health Secretary Backs National Prostate Cancer Screening
UK Health Secretary Wes Streeting declared support for a national prostate cancer screening program, prioritizing high-risk men (Black men or those with family history), following a poll showing 94% of GPs favor the initiative and research suggesting 775 extra early diagnoses annually.
Progress
44% Bias Score
NHS Cancer Care Reforms Following Sir Chris Hoy's Prostate Cancer Diagnosis
The UK government is investing £16 million with Prostate Cancer UK to improve early detection and is working to modernize the NHS to improve cancer care, following the recent diagnosis of six-time Olympic gold medallist Sir Chris Hoy with terminal prostate cancer, and the death of constituent Nathan...
NHS Cancer Care Reforms Following Sir Chris Hoy's Prostate Cancer Diagnosis
The UK government is investing £16 million with Prostate Cancer UK to improve early detection and is working to modernize the NHS to improve cancer care, following the recent diagnosis of six-time Olympic gold medallist Sir Chris Hoy with terminal prostate cancer, and the death of constituent Nathan...
Progress
60% Bias Score
£80M Scheme Aims to Keep 2 Million Patients Out of Hospitals
The English government is expanding a £80 million scheme to allow GPs to provide more care, preventing two million hospital visits by 2025/26, diverting 660,000 treatments from hospitals to communities between July and December 2024.
£80M Scheme Aims to Keep 2 Million Patients Out of Hospitals
The English government is expanding a £80 million scheme to allow GPs to provide more care, preventing two million hospital visits by 2025/26, diverting 660,000 treatments from hospitals to communities between July and December 2024.
Progress
40% Bias Score
AI Speeds Up Skin Cancer Diagnosis in UK Hospitals
An NHS hospital in London uses AI with 99% accuracy to clear benign skin cancer cases, freeing up doctors and reducing waiting times; the system has checked thousands and is expanding across the NHS.
AI Speeds Up Skin Cancer Diagnosis in UK Hospitals
An NHS hospital in London uses AI with 99% accuracy to clear benign skin cancer cases, freeing up doctors and reducing waiting times; the system has checked thousands and is expanding across the NHS.
Progress
40% Bias Score
Delays in UK Cross-Party Social Care Talks Jeopardize NHS Reform
Cross-party talks on UK social care reform, planned for February, have been delayed, jeopardizing Labour's NHS reform plans and sparking criticism amid concerns about the government's commitment to the issue, despite previous warnings from Health Secretary Wes Streeting.
Delays in UK Cross-Party Social Care Talks Jeopardize NHS Reform
Cross-party talks on UK social care reform, planned for February, have been delayed, jeopardizing Labour's NHS reform plans and sparking criticism amid concerns about the government's commitment to the issue, despite previous warnings from Health Secretary Wes Streeting.
Progress
44% Bias Score
NHS England Approves New Drug for Advanced Breast Cancer
A new drug, capivasertib, is now available on the NHS in England to treat advanced breast cancer, offering a potential benefit to 3,000 women yearly by slowing disease progression and shrinking tumors; it targets the AKT protein and was approved after successful clinical trials showing it doubled th...
NHS England Approves New Drug for Advanced Breast Cancer
A new drug, capivasertib, is now available on the NHS in England to treat advanced breast cancer, offering a potential benefit to 3,000 women yearly by slowing disease progression and shrinking tumors; it targets the AKT protein and was approved after successful clinical trials showing it doubled th...
Progress
40% Bias Score
NHS Announces Zero-Tolerance Policy on Violence Against Staff
The UK's health secretary, Wes Streeting, announced a zero-tolerance policy toward violence against NHS staff, mandating incident reporting and empowering staff to refuse care to abusive patients; this follows a 2024 survey showing that 14% of staff experienced physical violence and 25% faced harass...
NHS Announces Zero-Tolerance Policy on Violence Against Staff
The UK's health secretary, Wes Streeting, announced a zero-tolerance policy toward violence against NHS staff, mandating incident reporting and empowering staff to refuse care to abusive patients; this follows a 2024 survey showing that 14% of staff experienced physical violence and 25% faced harass...
Progress
52% Bias Score
Postcode Lottery Leaves Thousands of Prostate Cancer Patients Facing Increased Death Risk
In January 2024, only two-thirds of English NHS trusts met the 62-day target for prostate cancer diagnosis and treatment, leaving 1,559 men with delayed treatment, with 435 waiting over 104 days, highlighting a concerning 'postcode lottery' in care.
Postcode Lottery Leaves Thousands of Prostate Cancer Patients Facing Increased Death Risk
In January 2024, only two-thirds of English NHS trusts met the 62-day target for prostate cancer diagnosis and treatment, leaving 1,559 men with delayed treatment, with 435 waiting over 104 days, highlighting a concerning 'postcode lottery' in care.
Progress
48% Bias Score
Showing 1 to 12 of 231 results